ACH’s statement was included in Inside Health Policy’s article today on HRSA’s letter to J&J on their proposed 340 drug rebate program: “The drug company notified its customers of the shift last month and insists the policy is fully compliant with statutory requirements and may help ensure safety net hospitals are better able to meet the […]